Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans

Michael Burry says 'the end is nigh' for AI trade, channels The Joker

Wall Street Thinks Trumpflation Has Peaked, but There's an Unpleasant Surprise Looming for President Trump and Investors

The "Magnificent Seven" Ranked From Best to Worst Quarterly Performance -- and Which Ones Are the Best Buys Right Now

3 Magnificent Growth Stocks to Buy in July